2-Chloro-3-fluoro-5-(trifluoromethyl)pyridine: Lab Protocol

2-Chloro-3-fluoro-5-(trifluoromethyl)pyridine is a polyfluorinated, halogenated pyridine building block widely employed in the synthesis of agrochemical and pharmaceutical intermediates, offering multiple sites for selective nucleophilic aromatic substitution and cross-coupling reactions.

CAS Number

89402-37-9

Molecular Formula

C6H2ClF4N

Molecular Weight

199.54 g/mol

SKU / Product Code

C194774

Appearance

Colorless to pale yellow liquid or low-melting solid

Key Functional Groups

C–Cl, C–F, CF3, pyridine ring nitrogen

Scope and Intended Use

2-Chloro-3-fluoro-5-(trifluoromethyl)pyridine (SKU C194774) is a polyfluorinated halopyridine used as a versatile building block in medicinal chemistry, agrochemical research, and materials science. The compound contains three distinct electrophilic handles: the C-2 chloro substituent (activated toward nucleophilic aromatic substitution, SNAr), the C-3 fluoro group (displaceable under forcing SNAr conditions or selectively retained as a fluorine bioisostere), and the electron-withdrawing trifluoromethyl group at C-5 that enhances ring electrophilicity and metabolic stability of downstream targets.

This protocol covers safe receipt, storage, and practical use of the reagent in common synthetic transformations including SNAr, palladium-catalyzed cross-coupling, and amination reactions.

Safety, Handling, and Storage

Personal Protective Equipment (PPE): Always wear appropriate chemical-resistant gloves (nitrile or neoprene), safety goggles, and a lab coat when handling this compound. Work in a well-ventilated fume hood at all times.

Hazard Overview: The compound is an organofluorine halide and should be treated as a potential irritant to skin, eyes, and the respiratory tract. Avoid inhalation of vapors or dust. In case of skin or eye contact, flush immediately with copious water for at least 15 minutes and seek medical attention.

Storage Conditions: Store the reagent in a tightly sealed container under an inert atmosphere (nitrogen or argon) in a cool, dry location away from moisture, strong bases, and strong nucleophiles. Recommended storage temperature: 2–8 °C or as specified on the product label. Check the certificate of analysis (CoA) for lot-specific purity data upon receipt.

Waste Disposal: Dispose of all waste in accordance with local, institutional, and governmental regulations for halogenated organic solvents and reagents.

Protocol: Nucleophilic Aromatic Substitution (SNAr) at C-2

The C-2 chloro group is the primary site for SNAr reactions due to activation by both the ring nitrogen and the C-5 trifluoromethyl group.

1. Setup: Flame-dry or oven-dry all glassware. Charge the reaction flask with 2-Chloro-3-fluoro-5-(trifluoromethyl)pyridine (1.0 equiv) and the desired nucleophile (amine, alkoxide, or thiolate; 1.1–1.5 equiv) in an appropriate anhydrous polar aprotic solvent (e.g., DMF, DMSO, or NMP).
2. Base: Add an inorganic or organic base (e.g., K2CO3, Cs2CO3, or Et3N; 1.5–2.0 equiv) to neutralize the HX generated during reaction.
3. Reaction conditions: Stir the reaction at room temperature to 80 °C depending on nucleophile reactivity. Monitor progress by TLC or HPLC.
4. Workup: Upon complete conversion, dilute with ethyl acetate or diethyl ether, wash with water and brine, dry over anhydrous Na2SO4 or MgSO4, filter, and concentrate under reduced pressure.
5. Purification: Purify the crude product by silica gel column chromatography or recrystallization as appropriate.

Note: Optimize temperature, solvent, and base to achieve selectivity at C-2 over C-3 when both positions may be reactive.

Protocol: Palladium-Catalyzed Cross-Coupling

The C-2 C–Cl bond can participate in palladium-catalyzed cross-coupling reactions (e.g., Suzuki–Miyaura, Buchwald–Hartwig amination) to introduce aryl, heteroaryl, or amino groups.

1. Catalyst system: Select an appropriate Pd catalyst and ligand system (e.g., Pd(PPh3)4 or Pd2(dba)3 with XPhos or SPhos for challenging substrates).
2. Reagents: Combine the halopyridine (1.0 equiv), boronic acid or amine coupling partner (1.1–1.5 equiv), base (K3PO4, Cs2CO3, or KOAc; 2.0–3.0 equiv), and Pd catalyst (1–5 mol%) in degassed solvent (toluene/water, dioxane/water, or pure dioxane).
3. Atmosphere: Perform the reaction under inert atmosphere (N2 or Ar) using standard Schlenk or glovebox technique.
4. Temperature and time: Heat at 80–110 °C for 4–16 hours; monitor conversion by TLC or LC-MS.
5. Workup and purification: Filter through Celite to remove Pd black, extract, dry, concentrate, and purify by column chromatography.

Note: Electron-withdrawing groups on the pyridine ring generally facilitate oxidative addition, but the presence of multiple halogens requires careful optimization to achieve chemo-selectivity.

Troubleshooting and Quality Control

Low SNAr conversion: Increase reaction temperature incrementally (e.g., 60 → 100 °C), switch to a more polar solvent (DMSO vs. DMF), or use a stronger base. Ensure the nucleophile is anhydrous.

Multiple substitution products: Lower the equivalents of nucleophile to 1.05–1.1 equiv and reduce temperature. The C-3 fluoro group may also undergo SNAr under forcing conditions; adjust conditions to favor mono-substitution.

Low cross-coupling yield: Increase Pd loading, switch ligand to a more electron-rich or bulkier phosphine, or increase base equivalents. Ensure complete degassing of solvents to prevent catalyst poisoning.

Purity assessment: Analyze product by 1H NMR, 19F NMR, and HPLC (>95% purity recommended before biological or further synthetic use). Confirm identity by GC-MS or LC-MS.

Reagent quality: If results are inconsistent, verify the starting material purity using the Aladdin CoA and consider fresh lot procurement (SKU C194774).

Frequently asked questions

What is the most reactive site for nucleophilic aromatic substitution on 2-Chloro-3-fluoro-5-(trifluoromethyl)pyridine?

The C-2 chloro position is generally the most reactive site for SNAr due to synergistic activation by the adjacent ring nitrogen and the electron-withdrawing trifluoromethyl group at C-5. The C-3 fluoro group can also be displaced under more forcing conditions, but C-2 substitution typically predominates under mild to moderate conditions.

How should 2-Chloro-3-fluoro-5-(trifluoromethyl)pyridine be stored to maintain stability?

The compound should be stored in a tightly sealed container under an inert atmosphere (nitrogen or argon) at 2–8 °C, away from moisture, strong bases, and nucleophilic reagents. Always verify storage conditions on the Aladdin product label and certificate of analysis for the specific lot received.

Can this compound be used in palladium-catalyzed cross-coupling reactions?

Yes, the C-2 C–Cl bond is amenable to palladium-catalyzed cross-coupling reactions including Suzuki–Miyaura and Buchwald–Hartwig amination. Careful selection of catalyst, ligand, base, and solvent is required to achieve high chemoselectivity, particularly given the presence of multiple halogen substituents on the ring.

What analytical methods are recommended to confirm product identity and purity after reaction?

1H NMR and 19F NMR are the primary tools for structural confirmation given the multiple fluorine atoms present. HPLC is recommended for purity assessment (target >95%), and GC-MS or LC-MS should be used for molecular weight confirmation and identity verification.

Is 2-Chloro-3-fluoro-5-(trifluoromethyl)pyridine suitable for use as a pharmaceutical or agrochemical intermediate?

Yes, polyfluorinated halopyridines of this type are widely recognized as valuable building blocks in the synthesis of active pharmaceutical ingredients and agrochemicals, where the trifluoromethyl group contributes to enhanced lipophilicity, metabolic stability, and bioavailability of the final compounds. The specific suitability depends on the synthetic target and must be validated by the researcher.

References

1. Hagmann, W. K. The Many Roles for Fluorine in Medicinal Chemistry. Journal of Medicinal Chemistry, 2008, 51(15), 4359–4369. doi:10.1021/jm800219f
2. Böhm, H.-J. et al. Fluorine in Medicinal Chemistry. ChemBioChem, 2004, 5(5), 637–643. doi:10.1002/cbic.200300784
3. Clayden, J.; Greeves, N.; Warren, S. Organic Chemistry, 2nd ed.; Oxford University Press: Oxford, 2012; pp 479–510 (Nucleophilic Aromatic Substitution).
4. Nicolaou, K. C.; Bulger, P. G.; Sarlah, D. Palladium-Catalyzed Cross-Coupling Reactions in Total Synthesis. Angewandte Chemie International Edition, 2005, 44(29), 4442–4489. doi:10.1002/anie.200500368

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.